Updated Results From the Phase 1/2 MajesTEC-1 Study of Teclistamab, a B-Cell Maturation Antigen x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma

Authors :: Popat, Rakesh
Saad Usmani
Garfall, Alfred
Donk, Niels
Nahi, Hareth
San-Miguel, Jesus F.
Oriol, Albert
Nooka, Ajay
Martin, Thomas
Rosinol, Laura
Chari, Ajai
Karlin, Lionel
Benboubker, Lotfi
Mateos, Maria-Victoria
Bahlis, Nizar
Moreau, Philippe
Besemer, Britta
Martinez-Lopez, Joaquin
Sidana, Surbhi
Pei, Lixia
Trancucci, Danielle
Verona, Raluca
Girgis, Suzette
Olyslager, Yunsi
Jaffe, Mindy
Uhlar, Clarissa
Stephenson, Tara
Rampelbergh, Rian
Banerjee, Arnob
Goldberg, Jenna D.
Kobos, Rachel
Krishnan, Amrita
Source :: British Journal of Haematology, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, instname, Web of Science
Publication Year :: 2022
Publisher :: Blackwell Publishing Inc., 2022.

ISSN :: 13652141
Database :: OpenAIRE
Journal :: British Journal of Haematology, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, instname, Web of Science
Accession number :: edsair.dedup.wf.001..744e3ffab29398751e923d07d0a1d2e1

Tools